Brind.
  1. A price target raise for Hinge Health following the company's Q2 results and guidance, driven by the company's performance.

Daniel Perez was appointed Co-Founder and CEO of Hinge Health on August 6, 2025.

4 reports, 4 independent Updated Aug 6
Gone quiet Reached 3 outlets in its first 24 hours
Reports
4
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Daniel Perez was appointed Co-Founder and CEO of Hinge Health on August 6, 2025.

Who's involved

What this event is mainly about
Hinge HealthDaniel PerezHingeDaniel Perez

How it developed

Newest first. Tap a step to see who reported it.
  1. Hinge Health leadership update: Daniel Perez appointed CEO/Co-Founder.1 source
  2. Foundational details established for Hinge Health, including its ownership and CEO.1 source

Keep exploring

Part of

A price target raise for Hinge Health following the company's Q2 results and guidance, driven by the company's performance. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • themarketsdaily.com
  • Business WireHinge Health Reports Second Quarter 2025 Financial Results SAN FRANCISCO, August 05, 2025--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter en
  • Healthcare DiveHinge Health beats Wall Street expectations on revenue in first public earnings This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily
  • GuruFocus.comHinge Health Inc (HNGE) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... Release Date: August 05, 2025 For the complete transcript of the earnings call, please refer to the f